Kamlesh Haribhakti
Technik-/Wissenschafts-/F&E-Leiter bei Vensun Pharmaceuticals, Inc.
Profil
Kamlesh Haribhakti is currently the Director, Chief Scientific Officer & EVP at Vensun Pharmaceuticals, Inc. He previously worked as the Director-Product Development at Able Laboratories, Inc.
Aktive Positionen von Kamlesh Haribhakti
| Unternehmen | Position | Beginn |
|---|---|---|
Vensun Pharmaceuticals, Inc.
 Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Kamlesh Haribhakti
| Unternehmen | Position | Ende |
|---|---|---|
| ABLE LABORATORIES INC. | Vertrieb & Marketing | 07.12.2007 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Able Laboratories, Inc. | Health Technology |
Vensun Pharmaceuticals, Inc.
Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Health Technology |
